Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments

View ORCID ProfileCaroline Cake, View ORCID ProfileEmma Ogburn, Heather Pinches, Garry Coleman, View ORCID ProfileDavid Seymour, Fran Woodard, Sinduja Manohar, Marjia Monsur, Martin Landray, Gaynor Dalton, View ORCID ProfileAndrew D Morris, View ORCID ProfilePatrick F. Chinnery, UK COVID-19 National Core Studies Consortium, FD Richard Hobbs, Christopher Butler
doi: https://doi.org/10.1101/2021.01.15.21249724
Caroline Cake
1Health Data Research UK, Gibbs Building, 215 Euston Road, London, NW1 2BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline Cake
  • For correspondence: Caroline.cake{at}hdruk.ac.uk
Emma Ogburn
5Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma Ogburn
Heather Pinches
3NHS DigiTrials, Skipton House, 80 London Rd, Elephant and Castle, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garry Coleman
2NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London SE1 6LH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Seymour
1Health Data Research UK, Gibbs Building, 215 Euston Road, London, NW1 2BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Seymour
Fran Woodard
2NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London SE1 6LH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sinduja Manohar
1Health Data Research UK, Gibbs Building, 215 Euston Road, London, NW1 2BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjia Monsur
4DHSC, Department for Health and Social Care, 39 Victoria St, Westminster, London SW1H 0EU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Landray
6HDR UK Oxford, Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaynor Dalton
2NHS Digital, Skipton House, 80 London Rd, Elephant and Castle, London SE1 6LH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D Morris
1Health Data Research UK, Gibbs Building, 215 Euston Road, London, NW1 2BE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew D Morris
Patrick F. Chinnery
7Department of Clinical Neuroscience & Medical Research Council Mitochondrial Biology Unit, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick F. Chinnery
FD Richard Hobbs
5Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Butler
5Nuffield Department of Primary Care Health Sciences, University of Oxford, Gibson Building 1st Floor, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The COVID-19 pandemic has presented unique challenges for rapidly designing, initiating, and delivering therapeutic clinical trials. PRINCIPLE is the UK national platform investigating repurposed therapies for COVID-19 treatment of older people in the community at high risk of complications. Standard methods of patient recruitment were failing to meet the required pace and scale of enrolment.

This paper describes the development and appraisal of a near real-time, data-driven, ethical approach for enhancing recruitment in community care by contacting people with a recent COVID-19 positive test result from the central NHS Test and Trace service within 24-48 hours of their test result.

Methods A multi-disciplinary team was formed to solve the technical, ethical, public perception, logistical and information governance issues required to provide a near-real time (within 24-48 hours of receiving a positive test) feed of potential trial participants from test result data to the research team. PRINCIPLE was also given unique access to the Summary Care Record (SCR) to ensure safe prescribing, and to enable the trial team to quickly and safely bring consented patients into the trial. A survey of the public was used to understand public perceptions of the use of test data for this proposed methodology.

Results Prior to establishing the data service, PRINCIPLE registered on average 87 participants per week. This increased by up to 87 additional people registered per week from the test data, contributing to an increase from 1,013 recruits to PRINCIPLE at the start of October 2020 to 2,802 recruits by 20th December 2020.

While procedural caveats were identified by the public consultation, out of 2,639 people contacted by PRINCIPLE following a positive test result, no one raised a concern about being approached.

Conclusions This paper describes a novel approach to using near-real time NHS operational data to recruit community-based patients within a few days of presentation with acute illness.

This approach increased recruitment, and reduced time between positive test and randomisation, allowing more rapid evaluation of treatments and increased safety for participants. End-to-end public and patient involvement in the design of the approach provided evidence to inform information governance decisions.

Trial registration PRINCIPLE is funded by UK Research and Innovation and the Department of Health and Social Care through the National Institute for Health Research.

EudraCT number: 2020-001209-22

ISRCTN registry: ISRCTN86534580

REC number: 20/SC/058

IRAS number: 281958

Competing Interest Statement

Competing interests CCB and FDRH are the co-PIs for PRINCIPLE, CC, DS, SM and AM are employees of Health Data Research UK.

Clinical Trial

ISRCTN86534580

Funding Statement

Funding PRINCIPLE is funded by UKRI Urgent Public Health Priority COVID scheme. FDRH acknowledges part-funding from the National Institute for Health Research (NIHR) School for Primary Care Research, the NIHR Collaboration for Leadership in Health Research and Care (CLARHC) Oxford, the NIHR Oxford Biomedical Research Centre (BRC, UHT), and the NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative (MIC). The National Core Study Data & Connectivity programme is funded by UKRI. Health Data Research UK receives core funding from Medical Research Council (MRC), Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care, Health and Care Research Wales, Chief Scientists Office (Scotland), Public Health Agency (Northern Ireland), Wellcome and British Heart Foundation; together known as the Core Funders. NHS DigiTrials receives funding from the Digital Innovation Hubs programme, led by HDR UK. NHS Digital receives funding from the Data & Connectivity National Core Study, this has been used to fund the service delivery described in this paper. MJL receives core funding from HDR UK, NIHR Oxford Biomedical Research Centre, and MRC Population Health Research Unit. PFC is a Wellcome Trust Principal Research Fellow (212219/Z/18/Z), and a UK NIHR Senior Investigator, who receives support from the Medical Research Council Mitochondrial Biology Unit (MC_UU_00015/9), the Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), the Leverhulme Trust (RPG-2018-408), an MRC research grant (MR/S035699/1), an Alzheimer's Society Project Grant (AS-PG-18b-022) and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This trial has been ethically reviewed and approved by the South Central Berkshire Research Ethics Committee on the 26th March 2020 (REC reference: 20/SC/0158).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Email: Caroline.cake{at}hdruk.ac.uk; David.seymour{at}hdruk.ac.uk; Andrew.morris{at}hdruk.ac.uk; Sinduja.manohar{at}hdruk.ac.uk, garry.coleman{at}nhs.net; fran.woodard1{at}nhs.net; gaynor.dalton{at}nhs.net, h.pinches{at}nhs.net, Email: marjia.monsur{at}dhsc.gov.uk, Christopher.butler{at}phc.ox.ac.uk, Richard.hobbs{at}phc.ox.ac.uk; emma.ogburn{at}phc.ox.ac.uk, martin.landray{at}ndph.ox.ac.uk, pfc25{at}medschl.cam.ac.uk

Data Availability

All data generated or analysed during this study are included in this published article

  • LIST OF ABBREVIATIONS

    COPI
    Control of Patient Information Regulations
    COVID-19
    2019 novel coronavirus
    DHSC
    Department for Health and Social Care
    GP
    General Practitioner
    HDR UK
    Health Data Research UK
    ICO
    Information Commissioner’s Office
    LAS
    London Ambulance Service
    NCS
    National Core Study
    NHS
    National Health Service
    NHS
    111 NHS urgent medical help service
    NHSD
    NHS Digital
    PECR
    Privacy and Electronic Communications Regulations
    PRINCIPLE
    Platform Randomised Control Trial of Interventions against COVID-19 in older people
    RCGP
    Royal College of General Practitioners
    RCT
    Randomised Control Trial
    RECOVERY
    Randomised Evaluation of COVID-19 Therapy
    SCR
    Summary Care Record
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted January 15, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments
    Caroline Cake, Emma Ogburn, Heather Pinches, Garry Coleman, David Seymour, Fran Woodard, Sinduja Manohar, Marjia Monsur, Martin Landray, Gaynor Dalton, Andrew D Morris, Patrick F. Chinnery, UK COVID-19 National Core Studies Consortium, FD Richard Hobbs, Christopher Butler
    medRxiv 2021.01.15.21249724; doi: https://doi.org/10.1101/2021.01.15.21249724
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments
    Caroline Cake, Emma Ogburn, Heather Pinches, Garry Coleman, David Seymour, Fran Woodard, Sinduja Manohar, Marjia Monsur, Martin Landray, Gaynor Dalton, Andrew D Morris, Patrick F. Chinnery, UK COVID-19 National Core Studies Consortium, FD Richard Hobbs, Christopher Butler
    medRxiv 2021.01.15.21249724; doi: https://doi.org/10.1101/2021.01.15.21249724

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Primary Care Research
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (756)
    • Anesthesia (221)
    • Cardiovascular Medicine (3294)
    • Dentistry and Oral Medicine (364)
    • Dermatology (279)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
    • Epidemiology (13376)
    • Forensic Medicine (19)
    • Gastroenterology (899)
    • Genetic and Genomic Medicine (5153)
    • Geriatric Medicine (482)
    • Health Economics (783)
    • Health Informatics (3268)
    • Health Policy (1140)
    • Health Systems and Quality Improvement (1190)
    • Hematology (431)
    • HIV/AIDS (1017)
    • Infectious Diseases (except HIV/AIDS) (14629)
    • Intensive Care and Critical Care Medicine (913)
    • Medical Education (477)
    • Medical Ethics (127)
    • Nephrology (523)
    • Neurology (4925)
    • Nursing (262)
    • Nutrition (730)
    • Obstetrics and Gynecology (883)
    • Occupational and Environmental Health (795)
    • Oncology (2524)
    • Ophthalmology (724)
    • Orthopedics (281)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (543)
    • Pediatrics (1302)
    • Pharmacology and Therapeutics (550)
    • Primary Care Research (557)
    • Psychiatry and Clinical Psychology (4212)
    • Public and Global Health (7504)
    • Radiology and Imaging (1706)
    • Rehabilitation Medicine and Physical Therapy (1013)
    • Respiratory Medicine (980)
    • Rheumatology (480)
    • Sexual and Reproductive Health (497)
    • Sports Medicine (424)
    • Surgery (548)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (205)